Epigen Pharmaceuticals Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Epigen Pharmaceuticals General Information

Description

Developer of cardiac reperfusion therapies designed to prevent ischemia-reperfusion injury. The company's therapies involves the use of histone deacetylase (HDAC) inhibitors for reducing myocardial infarct size following acute myocardial infarction and restoring normal blood flow, thereby assisting physicians with an effective pharmaceutical intervention for protecting the cardiomyocyte from reperfusion injury.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 3160 Chestnut Street Suite- 200
  • Philadelphia, PA 19104
  • United States
+1 (215)
Primary Industry
Therapeutic Devices
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • 3160 Chestnut Street Suite- 200
  • Philadelphia, PA 19104
  • United States
+1 (215)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Epigen Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 17-Sep-2020 Completed Out of Business
1. Accelerator/Incubator 01-Jan-2014 Completed Startup
To view Epigen Pharmaceuticals’s complete valuation and funding history, request access »

Epigen Pharmaceuticals FAQs

  • When was Epigen Pharmaceuticals founded?

    Epigen Pharmaceuticals was founded in 2013.

  • Where is Epigen Pharmaceuticals headquartered?

    Epigen Pharmaceuticals is headquartered in Philadelphia, PA.

  • What industry is Epigen Pharmaceuticals in?

    Epigen Pharmaceuticals’s primary industry is Therapeutic Devices.

  • Is Epigen Pharmaceuticals a private or public company?

    Epigen Pharmaceuticals is a Private company.

  • What is Epigen Pharmaceuticals’s current revenue?

    The current revenue for Epigen Pharmaceuticals is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »